The global portable medical devices market size was accounted for USD 69.30 billion in 2024, grew to USD 77.14 billion in 2025 and is predicted to surpass around USD 202.52 billion by 2034, representing a healthy CAGR of 11.32% between 2025 and 2034. The North America portable medical devices market size was calculated at USD 27.30 billion in 2024 and is expected to grow at a fastest CAGR of 11.33% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Portable Medical Devices Market, by Product Type, 2025-2034
7.1.1. Therapeutics (Nebulizer, Insulin Pump, Image-guided Therapy Systems, Oxygen Concentrator)
7.1.1.1. Market Revenue and Forecast (2022-2034)
7.1.2. Smart Wearable Medical Devices
7.1.2.1. Market Revenue and Forecast (2022-2034)
7.1.3. Diagnostic Imaging (X-ray, CT, Endoscope, Ultrasound)
7.1.3.1. Market Revenue and Forecast (2022-2034)
7.1.4. Monitoring Devices
7.1.4.1. Market Revenue and Forecast (2022-2034)
7.1.5. Neuromonitoring
7.1.5.1. Market Revenue and Forecast (2022-2034)
7.1.6. Cardiac Monitoring
7.1.6.1. Market Revenue and Forecast (2022-2034)
7.1.7. Respiratory Monitoring
7.1.7.1. Market Revenue and Forecast (2022-2034)
7.1.8. Neonatal Monitoring
7.1.8.1. Market Revenue and Forecast (2022-2034)
7.1.9. Fetal Monitoring
7.1.9.1. Market Revenue and Forecast (2022-2034)
7.1.10. Vital Sign Monitors
7.1.10.1. Market Revenue and Forecast (2022-2034)
7.1.11. Hemodynamic Monitoring Systems
7.1.11.1. Market Revenue and Forecast (2022-2034)
7.1.12. Others
7.1.12.1. Market Revenue and Forecast (2022-2034)
8.1. Portable Medical Devices Market, by Application, 2025-2034
8.1.1. Cardiology
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Orthopedics
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. Gynecology
8.1.3.1. Market Revenue and Forecast (2022-2034)
8.1.4. Urology
8.1.4.1. Market Revenue and Forecast (2022-2034)
8.1.5. Gastrointestinal
8.1.5.1. Market Revenue and Forecast (2022-2034)
8.1.6. Neurology
8.1.6.1. Market Revenue and Forecast (2022-2034)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2022-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.2. Market Revenue and Forecast, by Application (2022-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.4.2. Market Revenue and Forecast, by Application (2022-2034)
10.1. Samsung Group
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. General Electric Company
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Koninklijke Philips N.V
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. VYAIRE
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Nox Medical
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. OMRON Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Medtronic Plc
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a MeetingNo cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client